
News|Articles|May 31, 2024
QSY2 Probes
Author(s)Thermo Fisher Scientific
Multiplex better with the newest additions to the TaqMan portfolio
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Implications of the First Liquid IV Infliximab Biosimilar
2
GSK Bets $50M on LTZ’s Immune-Engager Platform for Next-Gen Cancer Treatment
3
Why 503B Compounding Pharmacies Choose Prefabricated POD® Cleanrooms
4
Risks, Resource Strain, and Trade-Offs in FDA’s CNPV Pilot Program
5
